Attention Deficit Disorder with Hyperactivity [clinicaltrials_resource:26d9795050bc7e8c3121865e269c83cf]
Cocaine Abuse and Attention Deficit Disorder - 3 [clinicaltrials:NCT00000268]Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) [clinicaltrials:NCT00000388]Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00001206]Assessment of Attentional Functioning in Children With HIV-1 Infection [clinicaltrials:NCT00001497]Genetic Aspects of Neurologic and Psychiatric Disorders [clinicaltrials:NCT00001544]Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation [clinicaltrials:NCT00001915]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00004376]Brain Imaging in Children With AD/HD [clinicaltrials:NCT00008892]Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00011466]Treatment of Youth With ADHD and Anxiety [clinicaltrials:NCT00012584]Attention Deficit Disorder and Exposure to Lead [clinicaltrials:NCT00014898]Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 [clinicaltrials:NCT00015054]Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5 [clinicaltrials:NCT00015223]Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) [clinicaltrials:NCT00018863]Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [clinicaltrials:NCT00025779]Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers [clinicaltrials:NCT00026546]Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD [clinicaltrials:NCT00029614]Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children [clinicaltrials:NCT00031395]Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00046059]Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults [clinicaltrials:NCT00048360]Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00050050]Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00050622]Mental Health Services for Foster and Adopted Children [clinicaltrials:NCT00056303]Preventing Behavior Problems in Children With ADHD [clinicaltrials:NCT00057668]clinicaltrials:NCT00061087Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I [clinicaltrials:NCT00071656]Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00100295]Brain Changes in Children and Adolescents With Behavioral Problems [clinicaltrials:NCT00104039]Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00116259]clinicaltrials:NCT00118911clinicaltrials:NCT00136734clinicaltrials:NCT00142961Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00143767]Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning [clinicaltrials:NCT00143832]A Clinic-Based Prevention Program for Families of Depressed Mothers [clinicaltrials:NCT00149812]Efficacy and Safety of SPD465 in Adults With ADHD [clinicaltrials:NCT00150579]Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [clinicaltrials:NCT00150592]Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [clinicaltrials:NCT00150618]Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials [clinicaltrials:NCT00151957]Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD [clinicaltrials:NCT00151970]
condition browse [clinicaltrials_vocabulary:condition-browse]
Cocaine Abuse and Attention Deficit Disorder - 3 [clinicaltrials:NCT00000268]Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) [clinicaltrials:NCT00000388]Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00001206]Assessment of Attentional Functioning in Children With HIV-1 Infection [clinicaltrials:NCT00001497]Genetic Aspects of Neurologic and Psychiatric Disorders [clinicaltrials:NCT00001544]Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation [clinicaltrials:NCT00001915]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00004376]Brain Imaging in Children With AD/HD [clinicaltrials:NCT00008892]Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00011466]Treatment of Youth With ADHD and Anxiety [clinicaltrials:NCT00012584]Attention Deficit Disorder and Exposure to Lead [clinicaltrials:NCT00014898]Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 [clinicaltrials:NCT00015054]Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5 [clinicaltrials:NCT00015223]Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) [clinicaltrials:NCT00018863]Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [clinicaltrials:NCT00025779]Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers [clinicaltrials:NCT00026546]Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD [clinicaltrials:NCT00029614]Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children [clinicaltrials:NCT00031395]Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00046059]Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults [clinicaltrials:NCT00048360]Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00050050]Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00050622]Mental Health Services for Foster and Adopted Children [clinicaltrials:NCT00056303]Preventing Behavior Problems in Children With ADHD [clinicaltrials:NCT00057668]clinicaltrials:NCT00061087Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I [clinicaltrials:NCT00071656]Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00100295]Brain Changes in Children and Adolescents With Behavioral Problems [clinicaltrials:NCT00104039]Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00116259]clinicaltrials:NCT00118911clinicaltrials:NCT00136734clinicaltrials:NCT00142961Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00143767]Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning [clinicaltrials:NCT00143832]A Clinic-Based Prevention Program for Families of Depressed Mothers [clinicaltrials:NCT00149812]Efficacy and Safety of SPD465 in Adults With ADHD [clinicaltrials:NCT00150579]Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [clinicaltrials:NCT00150592]Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [clinicaltrials:NCT00150618]Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials [clinicaltrials:NCT00151957]Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD [clinicaltrials:NCT00151970]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Attention Deficit Disorder with Hyperactivity [clinicaltrials_resource:26d9795050bc7e8c3121865e269c83cf]
Bio2RDF identifier
26d9795050bc7e8c3121865e269c83cf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:26d9795050bc7e8c3121865e269c83cf
identifier
clinicaltrials_resource:26d9795050bc7e8c3121865e269c83cf
title
Attention Deficit Disorder with Hyperactivity
@en
type
label
Attention Deficit Disorder wit ...... 9795050bc7e8c3121865e269c83cf]
@en
Attention Deficit Disorder with Hyperactivity